Avricore Health Inc (AVCR) - Total Liabilities
Based on the latest financial reports, Avricore Health Inc (AVCR) has total liabilities worth CA$173.56K CAD (≈ $125.55K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset growth rate of Avricore Health Inc to track the company's year-over-year net asset growth rate.
Avricore Health Inc - Total Liabilities Trend (2000–2025)
This chart illustrates how Avricore Health Inc's total liabilities have evolved over time, based on quarterly financial data. See Avricore Health Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Avricore Health Inc Competitors by Total Liabilities
The table below lists competitors of Avricore Health Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Route1 Inc
V:ROI
|
Canada | CA$8.59 Million |
|
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
|
USA | $2.85 Million |
|
Mountview Estates PLC
LSE:MTVW
|
UK | GBX74.79 Million |
|
Visible Gold Mines Inc
V:VGD
|
Canada | CA$101.69K |
|
Fragbite Group AB
ST:FRAG
|
Sweden | Skr128.22 Million |
|
Fancy Wood Industries Public Company Limited
BK:FANCY
|
Thailand | ฿33.48 Million |
|
Hubify Ltd
AU:HFY
|
Australia | AU$3.73 Million |
|
Harvest Gold Corp
V:HVG
|
Canada | CA$362.92K |
Liability Composition Analysis (2000–2025)
This chart breaks down Avricore Health Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see AVCR company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.45 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Avricore Health Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Avricore Health Inc (2000–2025)
The table below shows the annual total liabilities of Avricore Health Inc from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CA$173.56K ≈ $125.55K |
-47.54% |
| 2024-12-31 | CA$330.82K ≈ $239.31K |
-37.49% |
| 2023-12-31 | CA$529.22K ≈ $382.83K |
-12.51% |
| 2022-12-31 | CA$604.89K ≈ $437.57K |
+616.04% |
| 2021-12-31 | CA$84.48K ≈ $61.11K |
-92.68% |
| 2020-12-31 | CA$1.15 Million ≈ $834.88K |
+71.27% |
| 2019-12-31 | CA$673.85K ≈ $487.45K |
+114.44% |
| 2018-12-31 | CA$314.24K ≈ $227.32K |
-21.85% |
| 2017-12-31 | CA$402.09K ≈ $290.87K |
+12.52% |
| 2016-12-31 | CA$357.34K ≈ $258.50K |
+45.13% |
| 2015-12-31 | CA$246.23K ≈ $178.12K |
+31.59% |
| 2014-12-31 | CA$187.12K ≈ $135.36K |
+18.94% |
| 2013-12-31 | CA$157.32K ≈ $113.80K |
-56.82% |
| 2012-12-31 | CA$364.30K ≈ $263.53K |
-72.83% |
| 2011-12-31 | CA$1.34 Million ≈ $970.00K |
+6.68% |
| 2010-12-31 | CA$1.26 Million ≈ $909.29K |
+12.86% |
| 2009-12-31 | CA$1.11 Million ≈ $805.68K |
+1881.27% |
| 2008-12-31 | CA$56.22K ≈ $40.67K |
-2.95% |
| 2007-12-31 | CA$57.92K ≈ $41.90K |
-22.01% |
| 2006-12-31 | CA$74.27K ≈ $53.72K |
+24.81% |
| 2005-12-31 | CA$59.50K ≈ $43.04K |
+99.24% |
| 2004-12-31 | CA$29.86K ≈ $21.60K |
-2.22% |
| 2003-12-31 | CA$30.54K ≈ $22.09K |
-70.51% |
| 2002-12-31 | CA$103.56K ≈ $74.91K |
+1833.89% |
| 2001-12-31 | CA$5.36K ≈ $3.87K |
+32.78% |
| 2000-12-31 | CA$4.03K ≈ $2.92K |
-- |
About Avricore Health Inc
Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018… Read more